The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 10, 2023
Filed:
Aug. 20, 2019
Applicant:
Quidel Corporation, San Diego, CA (US);
Inventors:
Jason J. Sun, San Diego, CA (US);
Jason McClure, San Diego, CA (US);
Assignee:
Quidel Corporation, San Diego, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/12 (2006.01); G01N 33/569 (2006.01); C07K 14/20 (2006.01); C07K 14/435 (2006.01);
U.S. Cl.
CPC ...
C07K 16/12 (2013.01); C07K 14/20 (2013.01); C07K 14/43504 (2013.01); G01N 33/56911 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/92 (2013.01); C07K 2319/00 (2013.01); G01N 2333/20 (2013.01); G01N 2800/26 (2013.01);
Abstract
Embodiments of the present disclosure relate to chimeric antibodies which specifically bind todecorin-binding protein A (DbpA) antigens and compositions or kits comprising such antibodies. The disclosure further relates to use of such antibodies in the detection ofsp. in samples, e.g., biological samples such as human blood and/or tissues of deer, ticks and other carriers of. Embodiments of the disclosure further relate to diagnosis and/or therapy of Lyme disease using the chimeric antibodies and/or compositions containing the chimeric antibodies.